Monday, 17 December 2018
Latest news
Main » Abbott Laboratories (NYSE:ABT) Shares Sold by Stearns Financial Services Group

Abbott Laboratories (NYSE:ABT) Shares Sold by Stearns Financial Services Group

12 January 2018

Noting its average daily volume at 3.87 million shares each day over the month, this signifies a pretty significant change over the norm. Mount Kellett Capital Management Lp sold 88,700 shares as Cf Inds Hldgs Inc (CF)'s stock declined 16.27%. The stock of Abbott Laboratories (NYSE:ABT) has "Buy" rating given on Monday, June 26 by RBC Capital Markets.

ABT traded at an unexpectedly low level on 10/01/2018 when the stock experienced a -0.15% loss to a closing price of $58.83. About 8.63 million shares traded.

Zacks Investment Research upgraded shares of Abbott Laboratories (NYSE:ABT) from a hold rating to a buy rating in a research report sent to investors on Tuesday, January 2nd. It has underperformed by 0.80% the S&P500.

COPYRIGHT VIOLATION NOTICE: "Verity & Verity LLC Has $7.27 Million Stake in Abbott Laboratories (ABT)" was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. The institutional investor held 279,106 shares of the property-casualty insurers company at the end of 2017Q3, valued at $25.65M, down from 290,509 at the end of the previous reported quarter. Eminence Capital Lp who had been investing in Cyberark Software Ltd for a number of months, seems to be bullish on the $1.48B market cap company. MD now owns 32,791,216 shares of the healthcare product maker's stock worth $1,386,741,000 after buying an additional 3,272,839 shares during the last quarter. It has outperformed by 9.17% the S&P500. KONDO CHRIS had sold 6,209 shares worth $1.01 million. (NYSE:CF) for 7,500 shares. During the same quarter in the previous year, the firm earned $0.59 earnings per share. analysts forecast that Abbott Laboratories will post 2.5 EPS for the current fiscal year. The healthcare product maker reported $0.66 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.65 by $0.01.

Noven Financial Group Inc, which manages about $207.77M and $166.44M US Long portfolio, upped its stake in Ishares (PFF) by 13,720 shares to 105,379 shares, valued at $4.09M in 2017Q3, according to the filing.

The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 1.90 for ABT and 2.20 for MDT, which implies that analysts are more bullish on the outlook for MDT. Abbott Laboratories had 92 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has "Outperform" rating by RBC Capital Markets given on Thursday, January 26. As per Thursday, August 3, the company rating was maintained by Cowen & Co. (NASDAQ:AAPL) on Wednesday, July 27 with "Buy" rating. Also, Chairman Miles D. White sold 276,886 shares of the firm's stock in a transaction dated Wednesday, December 6th. The firm has "Neutral" rating given on Thursday, April 28 by Piper Jaffray. As per Friday, June 16, the company rating was maintained by Jefferies. Also, insider Daniel Gesua Sive Salvadori sold 28,319 shares of the business's stock in a transaction that occurred on Thursday, December 14th. Argus Research upgraded Abbott Laboratories (NYSE:ABT) on Friday, February 5 to "Buy" rating. Virginia-based Culbertson A N has invested 0.45% in Ford Motor Company (NYSE:F). ABT's profit will be $1.27 billion for 19.99 P/E if the $0.73 EPS becomes a reality. It fall, as 40 investors sold CF shares while 147 reduced holdings. 116 funds opened positions while 640 raised stakes. Legal And General Grp Inc Public Ltd Company reported 8.74 million shares or 0.35% of all its holdings. Brown Advisory reported 0.12% stake. Sanders Capital Ltd Liability Company reported 7.87% in Apple Inc. 1St Source Commercial Bank has 0.39% invested in The Allstate Corporation (NYSE:ALL). Kentucky Retirement System stated it has 0.43% of its portfolio in Abbott Laboratories (NYSE:ABT). State Treasurer State Of Michigan has 109,637 shares. The share price was last seen -1.16% lower, reaching at $58.63 on October 01, 2018. Archford Cap Strategies Limited Company invested in 0.2% or 9,947 shares. Ftb Advsr accumulated 61,685 shares. Flossbach Von Storch AG now owns 14,514,773 shares of the healthcare product maker's stock worth $570,576,000 after buying an additional 4,936,655 shares during the last quarter. Abner Herrman And Brock Limited Com holds 201,549 shares. Boyd Watterson Asset Limited Liability Company Oh reported 42,398 shares or 1.12% of all its holdings. Hartford Fincl holds 0.01% or 184 shares. (NASDAQ:AMGN). Sentinel Asset Mngmt has invested 0.69% in Amgen Inc. Blue Chip Partners Inc sold 48,232 shares as the company's stock declined 13.59% while stock markets rallied. It also increased its holding in Wells Fargo & Co. Inc. lifted its position in Abbott Laboratories by 17.7% during the second quarter.

Since October 9, 2017, it had 0 buys, and 2 sales for $553,240 activity. The insider Fussell Stephen R sold $9.73 million. 2,000 shares were sold by Bracken Sharon J, worth $98,323. Abbott Laboratories (NYSE:ABT) has risen 15.90% since January 11, 2017 and is uptrending.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.01, from 0.88 in 2017Q2. It dropped, as 58 investors sold AMGN shares while 511 reduced holdings. 111 funds opened positions while 421 raised stakes. This is a boost from Abbott Laboratories's previous quarterly dividend of $0.26. Jefferies Group LLC lifted their price objective on shares of Abbott Laboratories from $46.00 to $47.00 and gave the company a "buy" rating in a research note on Friday, January 13th. Boston And Mngmt Incorporated holds 1.67% of its portfolio in Abbott Laboratories (NYSE:ABT) for 61,207 shares. Moreover, Ronna Sue Cohen has 3.41% invested in Abbott Laboratories (NYSE:ABT) for 83,852 shares. Advisor Prtnrs Limited Liability Com invested in 0.36% or 34,169 shares. Abbott Laboratories (NYSE:ABT) has risen 15.90% since January 10, 2017 and is uptrending. Spark Invest Mgmt Lc stated it has 4,000 shares. Ingalls & Snyder LLC now owns 244,230 shares of the healthcare product maker's stock valued at $10,846,000 after buying an additional 10,883 shares during the last quarter. Signaturefd Ltd Co reported 14,812 shares. Metropolitan Life Ins Company New York reported 0.28% stake.